Name: 6ix Investment Platform
Brand: 6ix

Latest Press Releases

Time	Headline
8m ago	Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
41m ago	Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
41m ago	Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
41m ago	Woodside Energy First Quarter Report for Period Ended 31 March 2026
41m ago	InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE

Suzhou Ribo Life Science Co (HK:6938) — investor relations, events, news, and company updates on 6ix.

Latest News

Revenue

HK$0

Community Chat